Skip to main content
Veterinary Medicines

Trilotab 60 mg chewable tablets for dogs

Authorised
  • Trilostane

Product identification

Medicine name:
Trilotab 60 mg chewable tablets for dogs
Trilotab vet, 60 mg närimistabletid koertele
Active substance:
  • Trilostane
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Trilostane
    60.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Chewable tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QH02CA01
Authorisation status:
  • Valid
Authorised in:
  • Estonia
Available in:
  • Estonia
Package description:
  • Aluminium-PVC/Aluminium/oPA blisters, containing 10 tablets. Cardboard box of 10 blisters of 10 tablets
  • Aluminium-PVC/Aluminium/oPA blisters, containing 10 tablets. Cardboard box of 3 blister of 10 tablets

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • CP-Pharma Handelsgesellschaft mbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • CP-Pharma Handelsgesellschaft mbH
Responsible authority:
  • State Agency Of Medicines
Authorisation number:
  • 1122823
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0373/003
Concerned member states:
  • Austria
  • Belgium
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Poland
  • Portugal
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)
Generic of:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Estonian (PDF)
Published on: 3/01/2024

Combined File of all Documents

English (PDF)
Published on: 22/08/2023
Updated on: 23/08/2023
Download

PuAR Trilotab NL_V_0373_001-005_DC 2023-08.pdf

English (PDF)
Published on: 25/08/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."